S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

PRTG Portage Biotech Inc

4.27

-0.10 (-2.29%)

14 Jan 2025 - Closed

Delayed by 15 minutes

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Portage Biotech (NASDAQ:PRTG)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Portage Biotech Charts.

Portage Biotech (NASDAQ:PRTG)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Portage Biotech Charts.

Portage Biotech Inc News

Form 424B3 - Prospectus [Rule 424(b)(3)]
Monday 6 January 2025 (1 week ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 6 January 2025 (1 week ago) • Edgar (US Regulatory)

Portage Biotech Announce Re-Launch of Adenosine Subsidiary as Independently Managed Company; Appointment of Peter Molloy to Lead New Company
Monday 6 January 2025 (1 week ago) • GlobeNewswire Inc.

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Friday 20 December 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Tuesday 17 December 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 17 December 2024 (4 weeks ago) • Edgar (US Regulatory)

Portage Biotech Announces Letter of Intent with Immunova for an Option to Acquire iOx Therapeutics, Ltd
Tuesday 17 December 2024 (4 weeks ago) • GlobeNewswire Inc.

Form 424B3 - Prospectus [Rule 424(b)(3)]
Saturday 14 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Saturday 14 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Friday 13 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 13 December 2024 (1 month ago) • Edgar (US Regulatory)

Portage Biotech Announces Receipt of Nasdaq Noncompliance Letter
Friday 13 December 2024 (1 month ago) • GlobeNewswire Inc.

More Portage Biotech Inc News Articles

Compam Fund Global Flexi...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions